Microbot Medical (MBOT) Assets (2010 - 2026)

Microbot Medical (MBOT) has reported Assets for 17 consecutive years, with $78.1 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 152.71% year-over-year to $78.1 million; the trailing twelve-month figure through Mar 2026 stood at $78.1 million (up 152.71% YoY), and the FY2025 full-year result was $81.5 million, up 1252.08% from the prior year.
• Assets retreated to $78.1 million in Q1 2026 per MBOT's latest filing, from $81.5 million in the prior quarter.
• Across five years, Assets topped out at $81.8 million in Q3 2025 and bottomed at $5.2 million in Q3 2024.
• Historically, Assets has averaged $23.9 million across 5 years, with a median of $9.5 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Assets tumbled 62.39% in 2022, then jumped 1469.89% in 2025.
• Over 5 years, Assets stood at $9.5 million in 2022, then dropped by 12.69% to $8.3 million in 2023, then decreased by 27.57% to $6.0 million in 2024, then jumped by 1252.08% to $81.5 million in 2025, then decreased by 4.27% to $78.1 million in 2026.
• According to Business Quant data, Assets over the past three periods registered $78.1 million, $81.5 million, and $81.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.